Literature DB >> 11312337

DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus.

S Pöhlmann1, F Baribaud, B Lee, G J Leslie, M D Sanchez, K Hiebenthal-Millow, J Münch, F Kirchhoff, R W Doms.   

Abstract

Dendritic cells (DCs) efficiently bind and transmit human immunodeficiency virus (HIV) to cocultured T cells and so may play an important role in HIV transmission. DC-SIGN, a novel C-type lectin that is expressed in DCs, has recently been shown to bind R5 HIV type 1 (HIV-1) strains and a laboratory-adapted X4 strain. To characterize the interaction of DC-SIGN with primate lentiviruses, we investigated the structural determinants of DC-SIGN required for virus binding and transmission to permissive cells. We constructed a panel of DC-SIGN mutants and established conditions which allowed comparable cell surface expression of all mutants. We found that R5, X4, and R5X4 HIV-1 isolates as well as simian immunodeficiency and HIV-2 strains bound to DC-SIGN and could be transmitted to CD4/coreceptor-positive cell types. DC-SIGN contains a single N-linked carbohydrate chain that is important for efficient cell surface expression but is not required for DC-SIGN-mediated virus binding and transmission. In contrast, C-terminal deletions removing either the lectin binding domain or the repeat region abrogated DC-SIGN function. Trypsin-EDTA treatment inhibited DC-SIGN mediated infection, indicating that virus was maintained at the surface of the DC-SIGN-expressing cells used in this study. Finally, quantitative fluorescence-activated cell sorting analysis of AU1-tagged DC-SIGN revealed that the efficiency of virus transmission was strongly affected by variations in DC-SIGN expression levels. Thus, variations in DC-SIGN expression levels on DCs could greatly affect the susceptibility of human individuals to HIV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312337      PMCID: PMC114220          DOI: 10.1128/JVI.75.10.4664-4672.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13.

Authors:  E J Soilleux; R Barten; J Trowsdale
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

2.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.

Authors:  I Mondor; S Ugolini; Q J Sattentau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4.

Authors:  S Ugolini; M Moulard; I Mondor; N Barois; D Demandolx; J Hoxie; A Brelot; M Alizon; J Davoust; Q J Sattentau
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

5.  In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model.

Authors:  S M Barratt-Boyes; S C Watkins; O J Finn
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

6.  DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans.

Authors:  S Pöhlmann; E J Soilleux; F Baribaud; G J Leslie; L S Morris; J Trowsdale; B Lee; N Coleman; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

7.  Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Authors:  E J Platt; K Wehrly; S E Kuhmann; B Chesebro; D Kabat
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

8.  Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells.

Authors:  P U Cameron; P S Freudenthal; J M Barker; S Gezelter; K Inaba; R M Steinman
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

9.  Human immunodeficiency virus type 2 infection associated with AIDS in West Africa.

Authors:  F Clavel; K Mansinho; S Chamaret; D Guetard; V Favier; J Nina; M O Santos-Ferreira; J L Champalimaud; L Montagnier
Journal:  N Engl J Med       Date:  1987-05-07       Impact factor: 91.245

10.  Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120.

Authors:  B M Curtis; S Scharnowske; A J Watson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

View more
  104 in total

1.  DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions.

Authors:  S Pöhlmann; G J Leslie; T G Edwards; T Macfarlan; J D Reeves; K Hiebenthal-Millow; F Kirchhoff; F Baribaud; R W Doms
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans.

Authors:  Carmen P Alvarez; Fátima Lasala; Jaime Carrillo; Oscar Muñiz; Angel L Corbí; Rafael Delgado
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

3.  Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.

Authors:  Mayla Hsu; Janet M Harouse; Agegnehu Gettie; Clarisa Buckner; James Blanchard; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1.

Authors:  James Lue; Mayla Hsu; David Yang; Preston Marx; Zhiwei Chen; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

5.  Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN.

Authors:  Cinzia Nobile; Arnaud Moris; Françoise Porrot; Nathalie Sol-Foulon; Olivier Schwartz
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 6.  DC-SIGN: binding receptor for HCV?

Authors:  Zhi-Hua Feng; Quan-Chu Wang; Qing-He Nie; Zhan-Sheng Jia; Yong-Xin Zhou
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

7.  Specific interaction of feline immunodeficiency virus surface glycoprotein with human DC-SIGN.

Authors:  Aymeric de Parseval; Stephen V Su; John H Elder; Benhur Lee
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus.

Authors:  Andrea Marzi; Thomas Gramberg; Graham Simmons; Peggy Möller; Andrew J Rennekamp; Mandy Krumbiegel; Martina Geier; Jutta Eisemann; Nadine Turza; Bertrand Saunier; Alexander Steinkasserer; Stephan Becker; Paul Bates; Heike Hofmann; Stefan Pöhlmann
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry.

Authors:  Dong P Han; Motashim Lohani; Michael W Cho
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

10.  Two-dimensional gel-based approaches for the assessment of N-Linked and O-GlcNAc glycosylation in human and simian immunodeficiency viruses.

Authors:  David R M Graham; Megan J Mitsak; Steven T Elliott; Dawn Chen; Stephen A Whelan; Gerald W Hart; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2008-12       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.